← FDA Drug Approvals (Drugs@FDA)

IMATINIB MESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2025-04-14

Drug application

FDA Application #

ANDA212975

Application type

Abbreviated New Drug Application (Generic)

Brand name

IMATINIB MESYLATE

Generic name

IMATINIB MESYLATE

Active ingredients

IMATINIB MESYLATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD V

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2025-04-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown